1h Free Analyst Time
The point-of-care testing (POCT) market in europe is forecasted to grow by $ 6.75 billion during 2023-2028, accelerating at a CAGR of 8.38% % during the forecast period. The report on the point-of-care testing (POCT) market in europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing geriatric population, increased focus on personalized medicine, and growing adoption of automated diagnostic devices in healthcare industry.
The point-of-care testing (POCT) market in europe is segmented as below:
By Type
- OTC testing
- Prescription- based testing
By Application
- Blood glucose testing
- Infectious diseases testing
- Cardiac markers testing
- Pregnancy and fertility testing
- Others
By Geographical Landscape
- Europe
The report on the point-of-care testing (POCT) market in europe covers the following areas:
- Point-Of-Care Testing (POCT) Market in Europe sizing
- Point-Of-Care Testing (POCT) Market in Europe forecast
- Point-Of-Care Testing (POCT) Market in Europe industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global point-of-care testing (poct) market in europe: A. Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, ACON Laboratories Inc., Becton Dickinson and Co., BioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Fluxergy Inc., Johnson and Johnson Services Inc., LifeScan IP Holdings LLC, Nova Biomedical Corp., OraSure Technologies Inc., PHC Holdings Corp., Sd Biosensor Inc., Siemens AG, Sinocare Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech Plc.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is shift from conventional testing methods to rapid diagnostic test."
According to the report, one of the major drivers for this market is the growing geriatric population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- A. Menarini Industrie Farmaceutiche Riunite Srl
- Abbott Laboratories
- ACON Laboratories Inc.
- Becton Dickinson and Co.
- bioMerieux SA
- Chembio Diagnostics Inc.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- Fluxergy Inc.
- Johnson and Johnson Services Inc.
- LifeScan IP Holdings LLC
- Nova Biomedical Corp.
- OraSure Technologies Inc.
- PHC Holdings Corp.
- Sd Biosensor Inc.
- Siemens AG
- Sinocare Inc.
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
- Trinity Biotech Plc
